title: [Newborn life threatening respiratory failure treatment with extracorporeal membrane oxygenation].
abstract: THE AIM of the study was to show first results of newborn life threatening respiratory failure treatment with extracorporeal membrane oxygenation (ECMO) in Poland.
  
  
  METHODS
  Nine newborns were treated with extracorporeal membrane oxygenation in Silesian Center for Heart Diseases. Newborns were born in 38 week of gestational age (36-41 weeks) with mean birth weight of 3490 g. Reasons for the referral were: meconium aspiration syndrome, infection, and pulmonary hypertension. Each newborn fulfilled an Extracorporeal Life Support Organization (ELSO) criteria for extracorporeal membrane oxygenation.
  
  
  RESULTS
  seven out of nine of patients treated with extracorporeal membrane oxygenation survived. Full clinical stabilization was reached about 6th hour of treatment. Mean extracorporeal oxygenation time was 162 hours. For eight newborns veno-venous method was applied and for one newborn veno-arterial method. Roller pump was used in 7 cases and centrifugal pomp in one case. Five newborns had uneventful treatment. During extracorporeal membrane oxygenation therapy we have observed several complications: PDA, hemorrhagic complications, renal failure, arterial hypertension, septicemia, tubing rupture.
  
  
  CONCLUSIONS
  extracorporeal oxygenation is an effective method of treatment for newborn life threatening respiratory failure. Obtained results do not differ much from Extracorporeal Life Support Organization register results. The most essential problem for extracorporeal membrane oxygenation therapy is correct qualification, early referral, safe transportation as well as the development of centers providing ECMO treatment.
authors.affiliation: Kliniczny Oddział Kardioanestezji, Slaska Akademia Medyczna, ul. Szpitalna 2, 41-800 Zabrze, Poland. ewuwa@wp.pl
authors.forename: Ewa
authors.initials: E
authors.lastname: Urbańska
authors.forename: Adam
authors.initials: A
authors.lastname: Grzybowski
authors.forename: Ireneusz
authors.initials: I
authors.lastname: Haponiuk
authors.forename: Roman
authors.initials: R
authors.lastname: Przybylski
authors.forename: Wojciech
authors.initials: W
authors.lastname: Walas
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Stempniewicz
authors.forename: Tomasz
authors.initials: T
authors.lastname: Szary
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Włoczka
authors.forename: Janusz H
authors.initials: JH
authors.lastname: Skalski
authors.forename: Marian
authors.initials: M
authors.lastname: Zembala
mesh_terms: D001724:Birth Weight; D015199:Extracorporeal Membrane Oxygenation; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007239:Infections / Q000150:complications / Q000628:therapy; D008297:Male; D008471:Meconium Aspiration Syndrome / Q000628:therapy; D010100:Oxygen / Q000627:therapeutic use; D010547:Persistent Fetal Circulation Syndrome / Q000150:complications / Q000628:therapy; D011044:Poland; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D010100:Oxygen